A statement released earlier today by FBR & Co about Metlife Inc (NYSE:MET) bumps the target price to $54.00
- Updated: November 27, 2016
Yesterday Metlife Inc (NYSE:MET) traded 0.18% higher at $55.45. The company’s 50-day moving average is $49.49 and its 200-day moving average is $44.38. The last closing price is up 24.95% from the 200-day moving average, compared to the S&P 500 which has decreased -0.03% over the same time. 2,307,669 shares of the stock were exchanged, down from an average trading volume of 7,214,390
Indicating a potential downside of -0.03%, FBR & Co bumped up the target of Metlife Inc (NYSE:MET) to $54.00
Previously on 2/08/2016, Raymond James reported on Metlife Inc (NYSE:MET) lowered the target price from $56.00 to $55.00. At the time, this indicated a possible upside of 0.47%.
See Chart Below
Metlife Inc has a 52 week low of $35.00 and a 52 week high of $55.49 with a P/E ratio of 17.04 The company’s market cap is currently $0.
Also covering Metlife Inc's price target, a total of 14 brokerages have issued a research note on the company. The average stock price target is $49.71 with five analysts rating the company a strong buy, six analysts rating the company a buy, six analysts rating the company a hold, zero equity analysts rating the company a underperform, and lastly zero equity analysts rating the stock a sell.
General Information About Metlife Inc (NYSE:MET)
MetLife, Inc. (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). Its Retail segment is organized into two businesses: Life & Other, and Annuities. Its Group, Voluntary & Worksite Benefits insurance products and services include life, dental, group short- and long-term disability, property and casualty, long-term care, accidental death and dismemberment, critical illness, vision, and accident and health coverages, as well as prepaid legal plans. Its Corporate Benefit Funding segment provides funding and financing solutions that help institutional customers manage liabilities primarily associated with their qualified, nonqualified and welfare employee benefit programs using a spectrum of life and annuity-based insurance and investment products.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.